San Francisco Bay Area biotech stories.
Friday, August 10, 2012
After 10 months, PacBio chief commercial officer Michael Glynn resigns
, who joined
Pacific Biosciences of California
less than a year ago, is stepping down as chief commercial officer
. The Menlo Park company (NASDAQ: PACB) broke the news Friday in a one-sentence filing with the Securities and Exchange Commission. The company did not say what prompted Glynn's resignation or hint at his personal plans.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)